Literature DB >> 19788028

The safety of omalizumab therapy in a patient with severe persistent allergic asthma and hepatitis C.

Leonardo Antonicelli, Giorgia Stagnozzi, Simona Giuliodoro, Alessandra Abbruzzetti, Chiara Massaccesi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19788028     DOI: 10.1016/S1081-1206(10)60194-9

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


× No keyword cloud information.
  1 in total

1.  Omalizumab for chronic spontaneous urticaria in "complex" patients: data from real-life clinical practice.

Authors:  Laura Vollono; Arianna Piccolo; Caterina Lanna; Maria Esposito; Mauro Bavetta; Elena Campione; Luca Bianchi; Laura Diluvio
Journal:  Drug Des Devel Ther       Date:  2019-09-06       Impact factor: 4.162

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.